NDTV Profit reported five Indian stock recommendations for Nov. 11, giving investors entry levels, targets and stop-losses while leaving the calls’ intended time frame unstated.
The report gave Gland Pharma Ltd. a current market price (CMP) of ₹3,285 per share. It attributed the call to market expert Sachin Janardan Sarvade, listing an entry range of ₹3,230 to ₹3,303, a ₹4,415 target and a ₹2,749 stop-loss. For Sansera Engineering Ltd., NDTV Profit listed a CMP of ₹4,650 and Sarvade’s suggested range of ₹4,555 to ₹4,654, followed by a ₹6,265 target and a ₹3,849 stop-loss.
For Dr Reddy’s Laboratories Ltd. and Union Bank of India Ltd., NDTV Profit attributed the recommendations to Ajit Mishra, senior vice president of research at Religare Broking. The outlet listed Dr Reddy’s CMP and suggested entry at ₹1,385, with a ₹1,460 target and a ₹1,345 stop-loss. For Union Bank, it gave a ₹197 CMP and entry, a ₹210 target and a ₹190 stop-loss.
NDTV Profit credited the Ashok Leyland Ltd. call to VLA Ambala, described as an analyst registered with the Securities and Exchange Board of India (SEBI) and founder of SMT Stock Market. The reported CMP was ₹174.86, with a suggested entry around ₹165, targets of ₹185 and ₹200, and a ₹155 stop-loss. The report did not explain the gap between its CMP and entry level.
The report did not link to the analysts’ original notes or posts, making the recommendations single-outlet reports from NDTV Profit. It did not specify when its CMP figures were recorded or how long the calls were intended to apply. The outlet’s disclaimer said the analysts’ views were their own and urged readers to consult an adviser before investing.
